F18 RADIOPHARMACEUTICALS

The Department of Veterans Affairs has issued a sources sought notice for the daily delivery of various F18 radiopharmaceuticals to the Nuclear Medicine Service at the Atlanta Veterans Affairs Medical Center in Decatur, Georgia. The required scope includes the provision of all labor, supervision, and transportation for agents such as F-18 FDG, NaF-F18, F18-Axumin, F18-Tauvid, F18-Cerianna, F18-Posluma, and F18-Pylarify, as well as beta-amyloid imaging agents and choline PET radiopharmaceuticals. Vendors must be established commercial radiopharmacies with at least 10 years of continuous operation and hold a license from the U.S. Nuclear Regulatory Commission or an Agreement State to prepare and distribute these materials.

Contract performance necessitates a needleless system for ordering, shipment, and returns that adheres to OSHA Biohazardous Waste Policy for the disposal of spent syringes. The provider is required to use FDA-approved cyclotrons for commercial production and must offer full credit for returns involving shipping errors, damaged products, recalls, or expired items in unopened containers. This procurement is classified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC Q527 for Medical- Nuclear Medicine.

The solicitation number for this market research effort is 36C24726Q0232. There is currently no set-aside designated for this requirement. Responses are due by January 26, 2026, and the primary point of contact is Natasha Mixon. One attachment, a Request for Information document, was provided with the initial posting on January 21, 2026.